Clinical utility of FDG-PET for the clinical diagnosis in MCI
Published inEuropean Journal of Nuclear Medicine and Molecular Imaging, vol. 45, no. 9, p. 1497-1508
Publication date2018
Abstract
Keywords
- Alzheimer Disease/diagnostic imaging
- Cognitive Dysfunction/diagnostic imaging
- Fluorodeoxyglucose F18
- Humans
- Lewy Body Disease/diagnostic imaging
- Positron-Emission Tomography
Affiliation entities
Research groups
Citation (ISO format)
ARBIZU, Javier et al. Clinical utility of FDG-PET for the clinical diagnosis in MCI. In: European Journal of Nuclear Medicine and Molecular Imaging, 2018, vol. 45, n° 9, p. 1497–1508. doi: 10.1007/s00259-018-4039-7
Main files (1)
Article (Published version)
Identifiers
- PID : unige:114052
- DOI : 10.1007/s00259-018-4039-7
- PMID : 29704037
ISSN of the journal1619-7070